Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1884 1
1885 2
1886 4
1887 10
1888 16
1889 13
1890 3
1891 4
1892 5
1893 2
1894 3
1895 1
1896 5
1897 1
1898 3
1902 1
1909 2
1945 3
1946 2
1947 5
1948 3
1949 9
1950 13
1951 9
1952 12
1953 15
1954 7
1955 15
1956 8
1957 10
1958 14
1959 19
1960 31
1961 19
1962 26
1963 25
1964 46
1965 27
1966 33
1967 50
1968 78
1969 74
1970 55
1971 85
1972 88
1973 85
1974 103
1975 84
1976 94
1977 108
1978 103
1979 126
1980 132
1981 115
1982 135
1983 132
1984 154
1985 157
1986 158
1987 146
1988 147
1989 174
1990 151
1991 115
1992 102
1993 95
1994 94
1995 96
1996 90
1997 98
1998 64
1999 62
2000 57
2001 57
2002 57
2003 68
2004 76
2005 89
2006 100
2007 92
2008 100
2009 120
2010 86
2011 101
2012 81
2013 98
2014 94
2015 100
2016 90
2017 84
2018 73
2019 95
2020 107
2021 89
2022 98
2023 93
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

5,864 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for antipyrine
Your search for zantipride retrieved no results
Factors influencing antipyrine elimination.
Stevenson IH. Stevenson IH. Br J Clin Pharmacol. 1977 Jun;4(3):261-5. doi: 10.1111/j.1365-2125.1977.tb00710.x. Br J Clin Pharmacol. 1977. PMID: 332216 Free PMC article. Review. No abstract available.
[Edaravone].
Abe K. Abe K. Nihon Rinsho. 2006 Oct 28;64 Suppl 7:548-53. Nihon Rinsho. 2006. PMID: 17461204 Review. Japanese. No abstract available.
Antipyrine pharmacokinetics in the tail-suspended rat model.
Brunner LJ, DiPiro JT, Feldman S. Brunner LJ, et al. J Pharmacol Exp Ther. 1995 Jul;274(1):345-52. J Pharmacol Exp Ther. 1995. PMID: 7616419
However, studies examining possible alterations in drug metabolism and pharmacokinetics are not readily available. Antipyrine is a marker of hepatic oxidative function and total body water. The purpose of our study was to examine the effects of simulated weightlessness on …
However, studies examining possible alterations in drug metabolism and pharmacokinetics are not readily available. Antipyrine is a ma …
HPLC determination of antipyrine metabolites.
Eichelbaum M, Sonntag B, Dengler HJ. Eichelbaum M, et al. Pharmacology. 1981;23(4):192-202. doi: 10.1159/000137550. Pharmacology. 1981. PMID: 7323136
A high-performance liquid chromatography method is described which allows for the simultaneous determination of antipyrine, 4-hydroxyantipyrine, norantipyrine and 3-hydroxyantipyrine. ...
A high-performance liquid chromatography method is described which allows for the simultaneous determination of antipyrine, 4-hydroxy …
Antipyrine clearance and metabolism in patients with psoriasis.
Kubota K, Ishizaki T, Chiba K, Takagi A, Nakagawa A, Nakamura K. Kubota K, et al. Br J Clin Pharmacol. 1986 Oct;22(4):455-62. doi: 10.1111/j.1365-2125.1986.tb02917.x. Br J Clin Pharmacol. 1986. PMID: 3768257 Free PMC article.
However, antipyrine half-life was significantly (P less than 0.05) shorter in nonsmoking psoriatrics than in nonsmoking controls. ...The total clearance of antipyrine and the partial clearances of antipyrine to its three main metabolites were significantly (P …
However, antipyrine half-life was significantly (P less than 0.05) shorter in nonsmoking psoriatrics than in nonsmoking controls. ... …
July 2017 ENCALS statement on edaravone.
Al-Chalabi A, Andersen PM, Chandran S, Chio A, Corcia P, Couratier P, Danielsson O, de Carvalho M, Desnuelle C, Grehl T, Grosskreutz J, Holmøy T, Ingre C, Karlsborg M, Kleveland G, Koch JC, Koritnik B, KuzmaKozakiewicz M, Laaksovirta H, Ludolph A, McDermott C, Meyer T, Mitre Ropero B, Mora Pardina J, Nygren I, Petri S, Povedano Panades M, Salachas F, Shaw P, Silani V, Staaf G, Svenstrup K, Talbot K, Tysnes OB, Van Damme P, van der Kooi A, Weber M, Weydt P, Wolf J, Hardiman O, van den Berg LH. Al-Chalabi A, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):471-474. doi: 10.1080/21678421.2017.1369125. Epub 2017 Oct 4. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28975816 Free article. Review. No abstract available.
An antipyrine based fluorescent probe for distinct detection of Al(3+) and Zn(2+) and its AIEE behaviour.
Maity S, Shyamal M, Maity R, Mudi N, Hazra P, Giri PK, Samanta SS, Pyne S, Misra A. Maity S, et al. Photochem Photobiol Sci. 2020 May 20;19(5):681-694. doi: 10.1039/c9pp00472f. Photochem Photobiol Sci. 2020. PMID: 32329762
A simple antipyrine based fluorescent probe, 4-[(2-hydroxy-3-methoxy-benzylidene)-amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one (OVAP), has been successfully synthesized using a one-step condensation method. ...
A simple antipyrine based fluorescent probe, 4-[(2-hydroxy-3-methoxy-benzylidene)-amino]-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3- …
Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
Eichelbaum M, Ochs HR, Roberts G, Somogyi A. Eichelbaum M, et al. Arzneimittelforschung. 1982;32(5):575-8. Arzneimittelforschung. 1982. PMID: 7201837 Clinical Trial.
Absolute bioavailability of an aqueous solution of antipyrine was on average 97%. Antipyrine half-life in smokers was significantly shorter (mean 9.7 h) as compared to non-smokers (mean 11.7 h). ...Thus, 3-hydroxymethyl-antipyrine formation is induced in smok …
Absolute bioavailability of an aqueous solution of antipyrine was on average 97%. Antipyrine half-life in smokers was signific …
Antipyrine metabolism in man: simultaneous determination of norantipyrine and 4-hydroxyantipyrine in urine by gas chromatography.
Inaba T, Fischer NE. Inaba T, et al. Can J Physiol Pharmacol. 1980 Jan;58(1):17-21. doi: 10.1139/y80-004. Can J Physiol Pharmacol. 1980. PMID: 7378903
A gas chromatographic method was developed to determine metabolites of antipyrine, norantipyhis method requires no derivatization and has ample sensitivity to determine these metabolites in urine after ingestion of antipyrine, a compound widely used as a hepatic pro …
A gas chromatographic method was developed to determine metabolites of antipyrine, norantipyhis method requires no derivatization and …
5,864 results